retatrutides Retatrutide vs Tirzepatide: Which Weight-Loss Drug Is Better? Retatrutide UK: New Triple-Agonist Weight

According to a study presented at the 2025 Society of Hematologic Oncology (SOHO) meeting, patients with PV who received GLP-1 therapy experienced : - *Reduced All-Cause Mortality*: Lower odds of death from any cause - *Lower Rates of Myelofibrosis Progression*: Decreased risk of progression to myelofibrosis, a condition where scar tissue builds up in the bone marrow - *Decreased Venous Thromboembolism (VTE)*: Fewer blood clots - *Fewer Hospitalizations*: Reduced need for hospitalization - *Reduced Risk of Acute Kidney Injury and Ischemic Stroke*: Lower risk of kidney damage and stroke

That said, GLP-1 RAs are not supposed to be used as monotherapy

A licensed provider sets your maintenance dose and adjusts it with you

Nat Aging 5 , 10971113 (2025)